Michael Drummond

Datos Biográficos

ID3927182
NOMBREMichael Drummond
NOMBRESMichael
APELLIDODrummond
FIRMADRUMMOND M
AFILIACIONESUniversity of York
ORCID0000-0002-6126-0944
VERIFICADOSí
TOTAL DE OBRAS20
TOTAL DE CITAS30
TOTAL COMO AUTOR20
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN1986
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H4

  • Generating a Student-Informed Teaching and Learning Conceptual Framework for GenAI in Business Schools

    Open AccessMichael Drummond, Gemma DaleARTICLEJournal of University Teaching…2026

    With the rise of GenAI, business schools must prepare students for a future workforce integrated with this technology. This paper details a case study from a UK business school that introduced GenAI into its curriculum for first-year undergraduates. Through a mixed-methods survey of 149 students, the study gathered feedback on newly implemented AI-focused learning activities. The findings reveal that students are highly engaged and recognise the …

  • Assessing the potential of HTA to inform resource allocation decisions in low-income settings

    Open AccessFrancesco Ramponi, Pakwanja Twea et al.ARTICLEFrontiers in Public Health2022

    Health technology assessment (HTA) offers a set of analytical tools to support health systems' decisions about resource allocation. Although there is increasing interest in these tools across the world, including in some middle-income countries, they remain rarely used in low-income countries (LICs). In general, the focus of HTA is narrow, mostly limited to assessments of efficacy and cost-effectiveness. However, the principles of HTA can be used…

  • Promoting innovation while controlling cost

    Open AccessMichael Anderson, Michael Drummond et al.ARTICLEHealth Policy2022

    New technologies, including pharmaceuticals and medical devices, can improve treatment options in healthcare but also bring concerns about rising healthcare costs. We undertake a narrative review of the United Kingdom's (UK) approach to appraising new health technologies. We find that the National Institute for Health and Care Excellence (NICE), Scottish Medicines Consortium (SMC) and All Wales Medicines Strategy Group (AWMSG) have contributed to…

  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement

    Open AccessDon Husereau, Michael Drummond et al.ARTICLEBMC Public Health2022

    Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being comp…

  • Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges

    Open AccessRita Daubner-Bendes, Rita Daubner‐Bendes et al.ARTICLEFrontiers in Public Health2021

    Objectives: Methodological challenges in the evaluation of medical devices (MDs) may be different for early and late technology adopter countries, as well as the potential health technology assessment (HTA) solutions to tackle them. This study aims to provide guidance to Central and Eastern European (CEE) countries on how to address key challenges of HTA for MDs with special focus on the transferability of scientific evidence. Methods: As part of…

  • Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe

    Open AccessSean Tunis, Eve Hanna et al.ARTICLEHealth Policy2021

    Transformative cell and gene therapies have now launched worldwide, and many potentially curative cell and gene therapies are in development, offering the prospect of significant health gains for patients. Access to these therapies depend on decisions made by health technology assessment (HTA) and payer organizations. We sought to describe the emerging cell and gene therapies market access landscape by analyzing 17 US commercial payer medical pol…

  • Economic evaluation of nutrition interventions

    Open AccessGiovanni Fattore, Carlo Federici et al.ARTICLEHealth Policy2021

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration

    Open AccessDon Husereau, Michael Drummond et al.ARTICLEValue in Health2013

  • Common Methodological Flaws in Economic Evaluations

    Michael Drummond, Mark SculpherARTICLEMedical Care2005Referencias: 34

    Economic evaluations are increasingly being used by those bodies such as government agencies and managed care groups that make decisions about the reimbursement of health technologies. However, several reviews of economic evaluations point to numerous deficiencies in the methodology of studies or the failure to follow published methodological guidelines. This article, written for healthcare decision-makers and other users of economic evaluations,…

  • Grading Systems for Cost-Effectiveness Studies

    Sally C Stearn, Sally C Stearns et al.ARTICLEMedical Care2003Referencias: 8

    From the Department of Health Policy and Administration, the University of North Carolina, Chapel Hill, North Carolina. †From the University of York, United Kingdom. Address correspondence and reprint requests to: Sally C. Stearns, PhD, Department of Health Policy and Administration, CB #7411, University of North Carolina, Chapel Hill, NC 27599-7411. E-mail: [email protected]

  • Economic evaluation under managed competition

    Open AccessMichael Drummond, Jonathan Cooke et al.ARTICLESocial Science & Medicine1997Citada por: 2Referencias: 6

  • Current status of economic appraisal of health technology in the European community

    Open AccessLinda Davies, Doug Coyle et al.ARTICLESocial Science & Medicine1994

  • The role of economic appraisal in health technology assessment

    Open AccessChris Selby Smith, David Hailey et al.ARTICLESocial Science & Medicine1994Citada por: 1Referencias: 5

  • Evaluation of health technology

    Open AccessMichael DrummondARTICLESocial Science & Medicine1994Citada por: 6Referencias: 13

  • Economic appraisal in the British national health service

    Open AccessChristopher Henshall, Michael DrummondARTICLESocial Science & Medicine1994Citada por: 4Referencias: 11

  • Cost-effectiveness league tables

    Open AccessMichael Drummond, George Torrance et al.ARTICLESocial Science & Medicine1993Citada por: 10Referencias: 24

  • The economic impact of Aids

    Michael Drummond, M F DrummondARTICLEAIDS Care1989

  • Health Care Technology

    Brian Ferguson, David Feeny et al.ARTICLECanadian Public Policy1988

  • Value for money in the health sector

    Open AccessAntonia Mills, Anne Mills et al.ARTICLEHealth Policy and Planning1987

    Since the Alma-Ata Declaration in 1978, primary health care (PHC) has been seen in most countries as a vital part of any strategy to improve the health of the population. Economic evaluations of PHC delivery and PHC activities are therefore needed to assist in decision-making on resource use in the health sector. A report was prepared on such economic evaluations in the Commonwealth and this paper summarizes those findings which relate to develop…

  • Guidelines for the clinical and economic evaluation of health care technologies

    Open AccessGordon Guyatt, Gordon Guaytt et al.ARTICLESocial Science & Medicine1986Citada por: 7Referencias: 42